Grafnos 0.25mg Capsule
By Grafnos
Rx
10 Capsule in a Strip

Composition
Tacrolimus(0.25mg)

Manufacturer - Akognos Life Sciences
Corporate & Registered Office, Akognos Life Sciences Pvt. Ltd., Manish Plaza, Third Floor, Plot No. 25, Sector-20 , Dwarka, New Delhi -110075

Expires on or after
July, 2025

liver
For individuals with liver disease, caution is advised when using Grafnos 0.25mg Capsule. It may be necessary to adjust the dose of the medication. It is important to consult your doctor before taking Grafnos 0.25mg Capsule if you have any liver-related issues.

kidney
Grafnos 0.25mg Capsule requires caution in patients with kidney disease. Adjusting the dose might be necessary. Always consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Grafnos 0.25mg Capsule. Drinking alcohol can have negative effects when combined with this medication.

driving
When taking Grafnos 0.25mg Capsule, be cautious while driving. This medication may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if you experience these effects.

pregnancy
Grafnos 0.25mg Capsule may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing this medication. Consult your doctor for advice.

breastfeeding
Caution is advised when using Grafnos 0.25mg Capsule during breastfeeding. Limited data indicates potential harm to the baby via breastmilk.
Habit Forming | No |
Chemical Class | Macrolide Lactams |
Therapeutic Class | - |
Action Class | Immunosuppressant- Calcineurin inhibitors |
₹131
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024